Literature DB >> 18563485

Breast-conserving surgery in Hong Kong Chinese women.

Dacita Suen1, Lorraine Chow, Ava Kwong.   

Abstract

BACKGROUND: Since the introduction of breast-conserving surgery (BCS), it has been increasingly accepted as the standard surgical option for suitable breast cancer patients in Western countries. However, there have been reports suggesting striking ethnic variations in those undergoing BCS. This study aimed to review the rate of BCS in Hong Kong Chinese breast cancer patients and the possible clinicopathologic and psychosocial factors that may have affected the choice of surgery.
METHODS: Patients in a university academic surgical center with early-stage breast cancer (stage I/II invasive carcinoma and carcinoma in situ) who underwent definitive surgery from January 2001 to December 2005 were studied. BCS was considered feasible for those with (1) the optimal tumor size for which an acceptable cosmetic outcome can be achieved after surgery, (2) unifocal disease, and (3) no contraindication for postoperative radiotherapy. The proportion of women undergoing BCS or mastectomy were compared. Factors affecting the choice of surgery were correlated.
RESULTS: Six hundred eighty female patients with early-stage breast cancer underwent surgery during the study period; 495 (72.8%) mastectomies, 149 (21.9%) BCS, and 36 (5.3%) mastectomies with immediate reconstruction were performed. For those patients who had mastectomies, 54.8% (271/495) had considered BCS as the initial surgical option. Among these, 19.6% (53/271) failed to have BCS performed due to margin involvement or extensive disease, and 80.4% (218/271) declined BCS and opted for mastectomy only. Age, marital status, and educational level were found to be independent significant factors affecting the choice of BCS.
CONCLUSION: The rate of BCS in Hong Kong is relatively low compared to that of Western countries. Patients who opted for mastectomies tended to be older, married, and have a lower educational level. Prospective studies on how sociocultural, clinicopathologic, and other factors important in treatment decision-making processes and psychosocial impact of choice of surgery are important so that an ethnic-specific assessment can be made. Suitability and acceptance of BCS by Chinese women should increase with better understanding and education.

Entities:  

Mesh:

Year:  2008        PMID: 18563485     DOI: 10.1007/s00268-008-9586-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  27 in total

1.  Increasing trends in the use of breast-conserving surgery in California.

Authors:  C R Morris; R Cohen; R Schlag; W E Wright
Journal:  Am J Public Health       Date:  2000-02       Impact factor: 9.308

Review 2.  Modified radical mastectomy versus breast conservation: psychosocial considerations.

Authors:  W S Schain; J H Fetting
Journal:  Semin Oncol       Date:  1992-06       Impact factor: 4.929

3.  Trends in breast-conserving surgery in Connecticut: no effect of negative publicity.

Authors:  A P Polednak
Journal:  Conn Med       Date:  1996-09

4.  Treatment decision making and adjustment to breast cancer: a longitudinal study.

Authors:  A L Stanton; M A Estes; N C Estes; C L Cameron; S Danoff-Burg; L M Irving
Journal:  J Consult Clin Psychol       Date:  1998-04

Review 5.  NIH consensus conference. Treatment of early-stage breast cancer.

Authors: 
Journal:  JAMA       Date:  1991-01-16       Impact factor: 56.272

6.  Breast conservation versus mastectomy: distress sequelae as a function of choice.

Authors:  S M Levy; R B Herberman; J K Lee; M E Lippman; T d'Angelo
Journal:  J Clin Oncol       Date:  1989-03       Impact factor: 44.544

7.  Psychological factors in the choice of treatment for breast cancer.

Authors:  G J Margolis; R L Goodman; A Rubin; T F Pajac
Journal:  Psychosomatics       Date:  1989       Impact factor: 2.386

8.  Differences in treatment patterns for localized breast carcinoma among Asian/Pacific islander women.

Authors:  Angela W Prehn; Barbara Topol; Susan Stewart; Sally L Glaser; Lilia O'Connor; Dee W West
Journal:  Cancer       Date:  2002-12-01       Impact factor: 6.860

9.  Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer.

Authors:  J A Jacobson; D N Danforth; K H Cowan; T d'Angelo; S M Steinberg; L Pierce; M E Lippman; A S Lichter; E Glatstein; P Okunieff
Journal:  N Engl J Med       Date:  1995-04-06       Impact factor: 91.245

10.  Socioeconomic status, immigration/acculturation, and ethnic variations in breast conserving surgery, San Francisco Bay area.

Authors:  Scarlett L Gomez; Anne-Marie France; Marion M Lee
Journal:  Ethn Dis       Date:  2004       Impact factor: 1.847

View more
  6 in total

1.  Efficacy of vinorelbine-based neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Hui Gao; Qiuyun Li; Wei Wei; Y I Jiang; Huawei Yang; Jianlun Liu
Journal:  Mol Clin Oncol       Date:  2015-06-09

2.  Breast-conserving surgery in Asian women: benefits and potential harm.

Authors:  George Zografos; Dimosthenis Ziogas
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

3.  Determinants of Breast-Conserving Therapy in the Asian Population: A Systematic Review.

Authors:  Maria Paz Galeano Machuca; Shelly Chien-Chien Cheng; Tony Hong-Ting Jou; Chih-Tao Cheng
Journal:  World J Surg       Date:  2020-10-13       Impact factor: 3.352

4.  Choice of management of southern Chinese BRCA mutation carriers.

Authors:  Ava Kwong; Connie H N Wong; Catherine Shea; Dacita T K Suen; Catherine L Y Choi
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

5.  Socioeconomic and clinical factors affecting the proportion of breast conserving surgery in Chinese women with breast cancer.

Authors:  Jingjing Liu; Dongdong Zhou; Teng Pan; Lixia Cao; Qianxi Yang; Jin Zhang
Journal:  Gland Surg       Date:  2022-02

6.  Effect of patient decision aids on decisional conflict and regret associated with breast cancer surgery: a randomized controlled trial.

Authors:  Shi-Qian Lin; Chih-Ming Su; Hsueh-Chi Wu; Yun-Yun Chou; Yu-Chun Yen; Ka-Wai Tam
Journal:  Breast Cancer       Date:  2022-05-19       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.